Class A1 scavenger receptor modulates glioma progression by regulating M2-like tumor-associated macrophage polarization

Oncotarget

Volumn 7, Issue 31, 2016, Pages 50099-50116

  Zhang, Hanwen ^a   Zhang, Wenbin ^b   Sun, Xuan ^a   Dang, Ruoyu ^a   Zhou, Rongmei ^a   Bai, Hui ^a   Ben, Jingjing ^a   Zhu, Xudong ^a   Zhang, Yan ^a   Yang, Qing ^a   Xu, Yong ^a   Chen, Qi ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Class A1 scavenger receptor; Glioma; Heat shock protein 70; Macrophage polarization; Tumor associated macrophage

Indexed keywords

CLASS A1 SCAVENGER RECEPTOR; HEAT SHOCK PROTEIN 70; SCAVENGER RECEPTOR A; STAT3 PROTEIN; STAT6 PROTEIN; UNCLASSIFIED DRUG; SCAF1 PROTEIN, HUMAN; SERINE ARGININE RICH SPLICING FACTOR; STAT3 PROTEIN, HUMAN; STAT6 PROTEIN, HUMAN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER MODEL; CANCER PROGNOSIS; CANCER TISSUE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE DELETION; GLIOMA; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INTRACELLULAR SIGNALING; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROGLIA; MIDDLE AGED; MONOCYTE; MOUSE; MURINE; NONHUMAN; POLARIZATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; TUMOR RECURRENCE; TUMOR VASCULARIZATION; UPREGULATION; ANIMAL; BRAIN TUMOR; C57BL MOUSE; CELL PROLIFERATION; DISEASE EXACERBATION; MACROPHAGE; METABOLISM; PATHOLOGY; PROGNOSIS;

ANIMALS; BRAIN NEOPLASMS; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; GLIOMA; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SERINE-ARGININE SPLICING FACTORS; STAT3 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR;

EID: 84981303047     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.10318     Document Type: Article

References (60)

1. Markovic DS, Vinnakota K, Chirasani S, Synowitz M, Raguet H, Stock K, Sliwa M, Lehmann S, Kalin R, van Rooijen N, Holmbeck K, Heppner FL, Kiwit J, et al. Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106:12530-12535.
2. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta neuropathologica. 2007; 114:97-109.
3. Kessenbrock K, Plaks V and Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010; 141:52-67.
4. Bagley RG. (2010). The tumor microenvironment. (New York: Springer).
5. Rigoni A, Colombo MP and Pucillo C. The Role of Mast Cells in Molding the Tumor Microenvironment. Cancer microenvironment. 2014.
6. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nature reviews Cancer. 2004; 4:71-78.
7. Condeelis J and Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006; 124:263-266.
8. Gallina G, Dolcetti L, Serafini P, De Santo C, Marigo I, Colombo MP, Basso G, Brombacher F, Borrello I, Zanovello P, Bicciato S and Bronte V. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. The Journal of clinical investigation. 2006; 116:2777-2790.
9. Dieterich LC, Mellberg S, Langenkamp E, Zhang L, Zieba A, Salomaki H, Teichert M, Huang H, Edqvist PH, Kraus T, Augustin HG, Olofsson T, Larsson E, et al. Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFbeta2 in vascular abnormalization. The Journal of pathology. 2012; 228:378-390.
10. Franklin RA, Liao W, Sarkar A, Kim MV, Bivona MR, Liu K, Pamer EG and Li MO. The cellular and molecular origin of tumor-associated macrophages. Science. 2014; 344:921-925.
11. Rosas M, Davies LC, Giles PJ, Liao CT, Kharfan B, Stone TC, O'Donnell VB, Fraser DJ, Jones SA and Taylor PR. The transcription factor Gata6 links tissue macrophage phenotype and proliferative renewal. Science. 2014; 344:645-648.
12. Tumor-associated macrophages are distinct from normal macrophages. Cancer discovery. 2014; 4:756.
13. Tripodo C, Sangaletti S, Piccaluga PP, Prakash S, Franco G, Borrello I, Orazi A, Colombo MP and Pileri SA. The bone marrow stroma in hematological neoplasms-a guilty bystander. Nature reviews Clinical oncology. 2011; 8:456-466.
14. Wang B, Liu H, Dong X, Wu S, Zeng H, Liu Z, Wan D, Dong W, He W, Chen X, Zheng L, Huang J and Lin T. High CD204+ tumor-infiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder. Oncotarget. 2015; 6:20204-20214. doi: 10.18632/oncotarget.3887.
15. Komohara Y, Ohnishi K, Kuratsu J and Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. The Journal of pathology. 2008; 216:15-24.
16. Ben J, Jin G, Zhang Y, Ma B, Bai H, Chen J, Zhang H, Gong Q, Zhou X, Zhang H, Qian L, Zhu X, Li X, et al. Class A scavenger receptor deficiency exacerbates lung tumorigenesis by cultivating a procarcinogenic microenvironment in humans and mice. American journal of respiratory and critical care medicine. 2012; 186:763-772.
17. Sangaletti S, Di Carlo E, Gariboldi S, Miotti S, Cappetti B, Parenza M, Rumio C, Brekken RA, Chiodoni C and Colombo MP. Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. Cancer research. 2008; 68:9050-9059.
18. Hu Y, Zhang H, Lu Y, Bai H, Xu Y, Zhu X, Zhou R, Ben J and Chen Q. Class A scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization. Basic research in cardiology. 2011; 106:1311-1328.
19. Xu Y, Qian L, Zong G, Ma K, Zhu X, Zhang H, Li N, Yang Q, Bai H, Ben J, Li X and Chen Q. Class A scavenger receptor promotes cerebral ischemic injury by pivoting microglia/macrophage polarization. Neuroscience. 2012; 218:35-48.
20. Zhu X, Zong G, Zhu L, Jiang Y, Ma K, Zhang H, Zhang Y, Bai H, Yang Q, Ben J, Li X, Xu Y and Chen Q. Deletion of class A scavenger receptor deteriorates obesity-induced insulin resistance in adipose tissue. Diabetes. 2014; 63:562-577.
21. Prabhudas M, Bowdish D, Drickamer K, Febbraio M, Herz J, Kobzik L, Krieger M, Loike J, Means TK, Moestrup SK, Post S, Sawamura T, Silverstein S, Wang XY and El Khoury J. Standardizing scavenger receptor nomenclature. Journal of immunology. 2014; 192:1997-2006.
22. Pucci F, Venneri MA, Biziato D, Nonis A, Moi D, Sica A, Di Serio C, Naldini L and De Palma M. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood. 2009; 114:901-914.
23. Hanisch UK and Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nature neuroscience. 2007; 10:1387-1394.
24. Lewis CE and Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer research. 2006; 66:605-612.
25. Farren MR, Carlson LM, Netherby CS, Lindner I, Li PK, Gabrilovich DI, Abrams SI and Lee KP. Tumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCbetaII abundance. Science signaling. 2014; 7:ra16.
26. Theriault JR, Adachi H and Calderwood SK. Role of scavenger receptors in the binding and internalization of heat shock protein 70. Journal of immunology. 2006; 177:8604-8611.
27. Ruffell B, Affara NI and Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends in immunology. 2012; 33:119-126.
28. Huang B, Zhao J, Li H, He KL, Chen Y, Chen SH, Mayer L, Unkeless JC and Xiong H. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer research. 2005; 65:5009-5014.
29. Ding P, Wang W, Wang J, Yang Z and Xue L. Expression of tumor-associated macrophage in progression of human glioma. Cell biochemistry and biophysics. 2014; 70:1625-1631.
30. Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, Quail DF, Olson OC, Quick ML, Huse JT, Teijeiro V, Setty M, Leslie CS, Oei Y, et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nature medicine. 2013; 19:1264-1272.
31. Komohara Y, Horlad H, Ohnishi K, Fujiwara Y, Bai B, Nakagawa T, Suzu S, Nakamura H, Kuratsu J and Takeya M. Importance of direct macrophage-tumor cell interaction on progression of human glioma. Cancer science. 2012; 103:2165-2172.
32. Hirota S, Miyamoto M, Kasugai T, Kitamura Y and Morimura Y. Crystalline light-chain deposition and amyloidosis in the thyroid gland and kidneys of a patient with myeloma. Archives of pathology & laboratory medicine. 1990; 114:429-431.
33. Roggendorf W, Strupp S and Paulus W. Distribution and characterization of microglia/macrophages in human brain tumors. Acta neuropathologica. 1996; 92:288-293.
34. Morris CS and Esiri MM. Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease. 1. Gliomas. Journal of the neurological sciences. 1991; 101:47-58.
35. Wierzba-Bobrowicz T, Kuchna I and Matyja E. Reaction of microglial cells in human astrocytomas (preliminary report). Folia neuropathologica/Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences. 1994; 32:251-252.
36. Zhou W, Ke SQ, Huang Z, Flavahan W, Fang X, Paul J, Wu L, Sloan AE, McLendon RE, Li X, Rich JN and Bao S. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nature cell biology. 2015; 17:170-182.
37. Lawrence T and Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nature reviews Immunology. 2011; 11:750-761.
38. Qian BZ and Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010; 141:39-51.
39. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegue E, Song H, Vandenberg S, Johnson RS, Werb Z and Bergers G. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer cell. 2008; 13:206-220.
40. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, Firestein GS, Gerber HP, Ferrara N and Johnson RS. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell. 2003; 112:645-657.
41. Hjelmeland AB, Lathia JD, Sathornsumetee S and Rich JN. Twisted tango: brain tumor neurovascular interactions. Nature neuroscience. 2011; 14:1375-1381.
42. Sica A and Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. The Journal of clinical investigation. 2007; 117:1155-1166.
43. Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM and Lynch M. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Molecular cancer therapeutics. 2008; 7:3129-3140.
44. Liu RY, Fan C, Liu G, Olashaw NE and Zuckerman KS. Activation of p38 mitogen-activated protein kinase is required for tumor necrosis factor-alpha-supported proliferation of leukemia and lymphoma cell lines. The Journal of biological chemistry. 2000; 275:21086-21093.
45. Robbins CS, Hilgendorf I, Weber GF, Theurl I, Iwamoto Y, Figueiredo JL, Gorbatov R, Sukhova GK, Gerhardt LM, Smyth D, Zavitz CC, Shikatani EA, Parsons M, et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nature medicine. 2013; 19:1166-1172.
46. Sun L, Wen JH, Sun HL, Shu XC, Hu F, Yin DC, Yang Q, Zeng YJ, Sun Y and Liu L. Perindopril attenuates renal tubulointerstitium injury by inhibiting scavenger receptor A over-expression in diabetic rats. Journal of endocrinological investigation. 2012; 35:511-515.
47. Cotena A, Gordon S and Platt N. The class A macrophage scavenger receptor attenuates CXC chemokine production and the early infiltration of neutrophils in sterile peritonitis. Journal of immunology. 2004; 173:6427-6432.
48. Usui HK, Shikata K, Sasaki M, Okada S, Matsuda M, Shikata Y, Ogawa D, Kido Y, Nagase R, Yozai K, Ohga S, Tone A, Wada J, et al. Macrophage scavenger receptor-adeficient mice are resistant against diabetic nephropathy through amelioration of microinflammation. Diabetes. 2007; 56:363-372.
49. Ma K, Xu Y, Wang C, Li N, Li K, Zhang Y, Li X, Yang Q, Zhang H, Zhu X, Bai H, Ben J, Ding Q, et al. A crosstalk between class A scavenger receptor and receptor for advanced glycation end-products contributes to diabetic retinopathy. American journal of physiology Endocrinology and metabolism. 2014:ajpendo 00378 02014.
50. Chen X, Zhang L, Zhang IY, Liang J, Wang H, Ouyang M, Wu S, Carvalho da Fonseca A, Weng L, Yamamoto Y, Yamamoto H, Natarajan R and Badie B. RAGE Expression in Tumor-associated Macrophages Promotes Angiogenesis in Glioma. Cancer research. 2014.
51. Ciocca DR and Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell stress & chaperones. 2005; 10:86-103.
52. Dodd K, Nance S, Quezada M, Janke L, Morrison JB, Williams RT and Beere HM. Tumor-derived inducible heat-shock protein 70 (HSP70) is an essential component of anti-tumor immunity. Oncogene. 2014.
53. Nylandsted J, Wick W, Hirt UA, Brand K, Rohde M, Leist M, Weller M and Jaattela M. Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion. Cancer research. 2002; 62:7139-7142.
54. Neyen C, Pluddemann A, Mukhopadhyay S, Maniati E, Bossard M, Gordon S and Hagemann T. Macrophage scavenger receptor a promotes tumor progression in murine models of ovarian and pancreatic cancer. Journal of immunology. 2013; 190:3798-3805.
55. Feiden S and Feiden W. [WHO classification of tumours of the CNS: revised edition of 2007 with critical comments on the typing und grading of common-type diffuse gliomas]. Der Pathologe. 2008; 29:411-421.
56. Kerber M, Reiss Y, Wickersheim A, Jugold M, Kiessling F, Heil M, Tchaikovski V, Waltenberger J, Shibuya M, Plate KH and Machein MR. Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer research. 2008; 68:7342-7351.
57. Stanley ER. The macrophage colony-stimulating factor, CSF-1. Methods in enzymology. 1985; 116:564-587.
58. Xu Y, Qian L, Zong G, Ma K, Zhu X, Zhang H, Li N, Yang Q, Bai H, Ben J, Li X, Xu Y and Chen Q. Class A scavenger receptor promotes cerebral ischemic injury by pivoting microglia/macrophage polarization. Neuroscience. 2012; 218:35-48.
59. Weischenfeldt J and Porse B. Bone Marrow-Derived Macrophages (BMM): Isolation and Applications. CSH protocols. 2008; 2008:pdb prot5080.
60. Zhu XD, Zhuang Y, Ben JJ, Qian LL, Huang HP, Bai H, Sha JH, He ZG and Chen Q. Caveolae-dependent endocytosis is required for class A macrophage scavenger receptor-mediated apoptosis in macrophages. The Journal of biological chemistry. 2011; 286:8231-8239.